Showing results (231-240 of 251) with videos related to

Sort By:
Pageof 26
Critical Reviews in Oncology/Hematology|July 15, 2010
The role of hypoxia inducible factor-1alpha in gynecological cancerLaura M S Seeber, Nicole Horrée, Marc A G G Vooijs, et al.
European Journal of Haematology|December 23, 2004
Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myelomaP Schütt, P Ebeling, U Buttkereit, et al.
Bone Marrow Transplantation|August 10, 2004
High-dose chemotherapy with autologous stem cell transplantation in patients with oligometastatic breast cancerP Bojko, A Welt, R Schleucher, et al.
Endocrine-Related Cancer|December 7, 2011
Promoter hypermethylation patterns in fallopian tube epithelium of BRCA1 and BRCA2 germ line mutation carriersJonathan G Bijron, Petra van der Groep, Eleonora B van Dorst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effectsM Stuschke, W Eberhardt, C Pöttgen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumorsA Korfel, M E Scheulen, H J Schmoll, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 3, 2007
Breast cancer patients' expectations in respect of the physician-patient relationship and treatment management results of a survey of 617 patientsG Oskay-Ozcelik, W Lehmacher, D Könsgen, et al.
Endocrine-Related Cancer|May 22, 2010
Methylation profiles of endometrioid and serous endometrial cancersLaura M S Seeber, Ronald P Zweemer, Luigi Marchionni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2006
Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumorsH Richly, B F Henning, P Kupsch, et al.
Pageof 26